Rheumatoid ArthritisePRATNCT05124782
Virtual Management of Rheumatoid Arthritis
An observational study of Rheumatoid Arthritis, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
The purpose of this study is to optimize the care of patients with RA seen in virtual consultation. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Rheumatoid Arthritis
- What is being tested?
- Rheumatoid Arthritis Impact of Disease questionnaire
- How many people
- 70 participants
- Where
- 1 siteFrance
- Study dates
- 30 Nov 2021to 22 Nov 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with rheumatoid arthritis followed in a tertiary center (University Hospital Cochin)
Who may be able to join
- Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
- Follow-up in the rheumatology department of Cochin Hospital
- Affiliated with a social security scheme
- Non-opposition to participating in the study
- Patients with a valid email address (registration to the virtual consultation system)
Who cannot join
- Opposition to participate to this research
- Inability to understand or speak French
- Patient under tutor or curator ship
- patients under medical state help
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of Rheumatoid Arthritis at the Time of Telemedicine
The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.
Read the detailed description
This study will be organized in two consecutive steps:
- A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period.
- The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.
- Conditions
- Rheumatoid Arthritis
- Being tested
- Rheumatoid Arthritis Impact of Disease questionnaire
- Keywords
- Rheumatoid arthritis, Virtual consultation, Telemedicine, Patient reported outcome
- Medical subject headings
- Arthritis, Rheumatoid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rheumatoid Arthritis Impact of Disease questionnaireOther
Rheumatoid Arthritis Impact of Disease questionnaire
| Study group | Role | What they receive |
|---|---|---|
| Patients with rheumatoid arthritis | Patients seen in virtual consultation Receives: Other: Rheumatoid Arthritis Impact of Disease questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of face to face consultation, hospitalization and therapeutic modifications
The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation
Measured: Inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2021
- Study start30 Nov 2021
- Primary completion22 Nov 2023
- Study completion22 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Rheumatoid ArthritisStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- URC-CIC Paris Descartes Necker Cochin
- Responsible party
- Sponsor
- Investigators
- Jérôme AVOUAC, MD, PhD, Principal investigator, Assistance Publique - Hôpitaux de Paris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05124782
- Sponsor's protocol ID
- APHP210550
- Acronym
- ePRAT
- Status last verified
- Sep 2025
- First submitted
- 22 Oct 2021
- Last updated
- 15 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Rheumatoid Arthritis at the Time of Telemedicine
- ClinicalTrials.gov ID
- NCT05124782
- Acronym / sponsor ID
- ePRAT / APHP210550
- Conditions
- Rheumatoid Arthritis
- Keywords
- Rheumatoid arthritis, Virtual consultation, Telemedicine, Patient reported outcome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- URC-CIC Paris Descartes Necker Cochin
- Study start
- 30 Nov 2021 (actual)
- Primary completion
- 22 Nov 2023 (actual)
- Study completion
- 22 Nov 2023 (actual)
- First posted
- 18 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.
Detailed description
This study will be organized in two consecutive steps:
- A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period.
- The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients with rheumatoid arthritis | – | Other: Rheumatoid Arthritis Impact of Disease questionnairePatients seen in virtual consultation |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients with rheumatoid arthritis followed in a tertiary center (University Hospital Cochin)
Key inclusion criteria (5 listed)
- Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
- Follow-up in the rheumatology department of Cochin Hospital
- Affiliated with a social security scheme
- Non-opposition to participating in the study
- Patients with a valid email address (registration to the virtual consultation system)
Key exclusion criteria (4 listed)
- Opposition to participate to this research
- Inability to understand or speak French
- Patient under tutor or curator ship
- patients under medical state help
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rheumatoid Arthritis Impact of Disease questionnaireRheumatoid Arthritis Impact of Disease questionnaire | Other | Patients with rheumatoid arthritis |
Primary outcome
Rate of face to face consultation, hospitalization and therapeutic modifications
Time frame: Inclusion
The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Rheumatoid Arthritis
RecruitingPhase 2
Study of PTC844 in Participants With Active Rheumatoid Arthritis
Rheumatoid Arthritis
Not yet recruitingPhase 1
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
Rheumatoid Arthritis and Systemic Lupus Erythematosus
Not yet recruitingPhase 1
R-2487 in Patients With Sjogren's Syndrome (SjD)
Sjogren's Syndrome, Sjögren
RecruitingPhase 1
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Active, not recruitingPhase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jérôme AVOUAC, MD, PhD principal investigator
Assistance Publique - Hôpitaux de Paris
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Rheumatoid Arthritis, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of face to face consultation, hospitalization and therapeutic modifications (time frame: Inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.